Clinical Report: Klinefelter Syndrome: A Comprehensive Review of Systemic Effects

Overview

Klinefelter syndrome (KS) is the most common male sex chromosome aneuploidy, affecting 1 in 450–600 male births. This review highlights the multisystem involvement in KS, including metabolic, cardiovascular, and neurocognitive consequences.

Background

Klinefelter syndrome is characterized by a 47,XXY karyotype and is associated with various clinical manifestations beyond reproductive issues. The syndrome's prevalence and the high rate of undiagnosed cases underscore the importance of awareness among healthcare professionals.

Data Highlights

Men with KS have a reported prevalence of metabolic syndrome of 34-44%, compared to approximately 10% in healthy male controls.

Key Findings

• Approximately 75% of individuals with KS remain undiagnosed throughout their lifetime.
• Metabolic abnormalities in KS significantly increase the risk of metabolic syndrome and type 2 diabetes.
• Individuals with KS exhibit elevated cardiovascular and thromboembolic risk.
• There is a notable association between KS and various malignancy patterns, including breast cancer.
• Testosterone replacement therapy (TRT) has systemic impacts that require careful monitoring.

Clinical Implications

Healthcare providers should be aware of the metabolic, cardiovascular, and neurocognitive health issues associated with KS.

Conclusion

Klinefelter syndrome presents significant systemic health challenges.

Related Resources & Content

1. Zitzmann, M., European academy of andrology guidelines on Klinefelter Syndrome, 2021 -- Andrology
2. Metabolism and Type 2 Diabetes Across Life Stages in Klinefelter Syndrome, 2025 -- PMC
3. Cardiovascular risk and mortality in men receiving testosterone replacement therapy for Klinefelter syndrome in Denmark, 2025 -- Aarhus University
4. Endocrine Reviews — New Horizons in Klinefelter Syndrome: Current Evidence, Gaps, and Research Priorities
5. The Journal of Clinical Endocrinology & Metabolism — Recent Advances in Managing Physical, Psychological, and Quality of Life Aspects in Klinefelter Syndrome
6. The Journal of Clinical Endocrinology & Metabolism — Assessment of Body Composition via DXA in Individuals with Klinefelter and Kallmann Syndromes: Findings from the Kama Study
7. The Journal of Clinical Endocrinology & Metabolism — Management Strategies for Patients Diagnosed with Turner Syndrome
8. New Horizons in Klinefelter Syndrome: Current Evidence, Gaps, and Research Priorities
9. Recent Advances in Managing Physical, Psychological, and Quality of Life Aspects in Klinefelter Syndrome
10. European academy of andrology guidelines on Klinefelter Syndrome Endorsing Organization: European Society of Endocrinology - Zitzmann - 2021 - Andrology - Wiley Online Library
11. Continuity of care in Klinefelter syndrome: age-adapted modules for standardized clinical data collection (I-KS) - PMC
12. European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2025 Update on Male Infertility - ScienceDirect
13. Metabolism and Type 2 Diabetes Across Life Stages in Klinefelter Syndrome: A Population-Based Cohort Study - PMC
14. Cardiovascular risk and mortality in men receiving testosterone replacement therapy for Klinefelter syndrome in Denmark: a retrospective cohort study - Aarhus University
15. Klinefelter Syndrome Identified by Next-generation Sequencing as a Risk Factor for Venous Thromboembolism: A Single-institution Study - PubMed
16. Male Breast Cancer Treatment (PDQ®) - NCI
17. Surgical sperm retrieval in patients with nonmosaic Klinefelter syndrome (47,XXY) may be safely delayed until adulthood: a systematic review and meta-analysis
18. Testosterone Effects on Short-term Physical, Hormonal, and Neurodevelopmental Outcomes (TESTO) in Infants With 47,XXY | Endocrine Society
19. Effect of testosterone treatment during puberty in boys with Klinefelter syndrome (The TIPY Study): protocol for a nationwide randomised, double-blinded, placebo-controlled study - PMC